Transcutaneous Electrical Stimulation in Obstructive Sleep Apnea
NCT ID: NCT04932486
Last Updated: 2023-04-14
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
42 participants
INTERVENTIONAL
2021-05-26
2023-04-13
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Domiciliary Transcutaneous Electrical Stimulation in Obstructive Sleep Apnoea
NCT03160456
Clinical Trial of a Rehabilitation Device Based on Electrostimulation for Obstructive Sleep Apnoea
NCT04607343
Continuous Transcutaneous Electrical Stimulation in Sleep Apnoea
NCT01661712
Early Feasibility Study of Transcutaneous Upper Airway Stimulation in Obstructive Sleep Apnea
NCT05881512
Effect of Upper Airway Stimulation in Patients With Obstructive Sleep Apnea
NCT03760328
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Transcutaneous electrical stimulation
Participants will be asked to use the stimulator for 6 weeks at home. The study objectives will be evaluated after 6 weeks post-activation of the device.
Transcutaneous electrical stimulation
Transcutaneous electrical stimulation of the upper airway muscles
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Transcutaneous electrical stimulation
Transcutaneous electrical stimulation of the upper airway muscles
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Patients who do not tolerate or do not accept positive airway pressure therapy
Exclusion Criteria
* Unable or incapable of providing informed written consent
* Unwilling or incapable of returning to all follow-up visits and sleep studies, including evaluation procedures and filling out questionnaires
* Significant co-morbidities making the patient unable or inappropriate to participate in the trial
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Sunrise
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Jean-Benoit Martinot
Role: PRINCIPAL_INVESTIGATOR
Respisom
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Respisom
Namur, , Belgium
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
B7072020000095
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.